23.08.2022 • NewsMaerskMethanolfossil fuels

Maersk and China’s Debo Partner on Methanol

Danish shipping giant A.P. Moller-Maersk has signed a Letter of Intent with Chinese bioenergy enterprise Debo to take the full output of its proposed green methanol plant.

© Maersk
© Maersk

Debo plans to build a 200,000 t/y plant from agricultural residues, and commercial operations are scheduled to start by autumn 2024.

“The use of green methanol as marine fuel to replace the existing fossil fuel is groundbreaking in the container shipping history and will strongly promote the development of green shipping,” said Zhang Shoujun, Debo’s chairman and general manager. Together, the partners will be able to realize the commercial production and industrial conversion of green methanol and contribute to reduce greenhouse gas emissions, he added.

Maersk’s head of green fuels sourcing, Berit Hinnemann, added that the availability of green methanol at scale is critical to its fleet’s transition to sustainable energy. The shipping line has set 2040 as its goal for achieving net-zero emissions.

In March, the shipping group announced partnerships with six companies, namely CIMC ENRIC, European Energy, Green Technology Bank, Orsted, Proman and WasteFuel, with the intent of sourcing at least 730,000 t/y of green methanol by the end of 2025 – well above that needed for its first 12 green container vessels currently on order. The vessels will each have capacity of 16,000 containers.

Maersk added that it will keep working with a wide-ranging group of leading companies on these and further projects to accelerate the urgent transition to green energy.

Author: Elaine Burridge, Freelance Journalist

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read